Connect your AI

Opus Genetics IRD Total Current Assets

Total Current Assets at other companies

AbbVieABBV

$33.53B+21.2%

MeiraGTx Holdings plcMGTX

$96.2M+20.4%

4D Molecular TherapeuticsFDMT

$405.36M+21.9%

Opko HealthOPK

$535.36M-27.4%

Kodiak Sciences IncKOD

$175.26M+22.8%

Regeneron PharmaceuticalsREGN

$18.21B+3.6%

Other financials

Income statement

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

Operating cash flow-$12.7M-41.5%

Valuation

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opus Genetics's total current assets?: Opus Genetics (IRD) reported total current assets of $66.6M in Q1 2026.
How has Opus Genetics's total current assets changed year-over-year?: Opus Genetics's total current assets increased by 39.0% year-over-year, from $47.93M to $66.6M.
What is the long-term trend for Opus Genetics's total current assets?: Over 5 years (2020 to 2025), Opus Genetics's total current assets has grown at a 23.1% compound annual growth rate (CAGR), from $17.67M to $50.04M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.